MAMeysam Arbuzia

Meysam Arbuzia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meysam Arbuzia has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Air pollution and kidney disease; a comprehensive updated overview of recent evidence on functional and structural alterations

    by Iman Ghasemzadeh, Mohadeseh Javadi, Pourya Bagherian Kenari, Ali Emadzadeh, Meysam Ziaei Mehr, Elham Ahmadipour, Hossein Mardanparvar, Seyedeh Arefeh Javadi

    The association between air pollution and renal health has gained increasing attention in recent years, with evidence suggesting that prolonged exposure to air pollution poses significant threats to both renal function and structural integrity of kidneys, with both immediate and long-term consequences on kidney health. Studies have indicated that various air pollutants are linked to the onset and progression of chronic kidney disease (CKD) and other renal disorders. The evidence links short-term increases in pollutant concentrations to declines in glomerular filtration rates, while long-term exposure is associated with a heightened risk of CKD and structural damage to renal tissues. The mechanisms through which air pollution impacts renal health, systemic inflammation, oxidative stress, endothelial dysfunction, and direct nephrotoxicity highlight the urgent need for public health policies aimed at improving air quality and protecting kidney health. The evidence emphasizes air pollution as a critical environmental risk factor contributing to kidney diseases globally.

  • Open Access

    Role of lipoprotein (a) in kidney diseases; a review of recent data

    by Sara Ghaseminejad Kermani, Jalal Rezaei, Sara Rasta, Meysam Arbuzia, Tayabeh Bahmani, Hossein Mardanparvar

    Lipoprotein (a) is a type of lipoprotein that consists of a cholesterol-rich low-density lipoprotein particle bound to a unique protein called apolipoprotein (a). A strengthened risk of vascular diseases, such as stroke and coronary artery disease is accompanied by elevated levels of this protein. However, recent research has also highlighted the potential role of lipoprotein (a) in kidney-related conditions. Lp (a) appears to play a significant role in kidney diseases. An increased risk of kidney disease development and progression, diabetic nephropathy and renal artery stenosis, and renal transplant dysfunction accompanies high plasma values of Lp (a).

  • Open Access

    Limb amputation following sodium-glucose cotransporter type 2 inhibitor therapy

    by Meysam Alipour, Jalal Rezaei, Venus Shahabi Rabori, Meysam Arbuzia, Amin Norouzbeygi, Sara Rasta, Hossein Mardanparvar, Mobin Forghan

    This review article examines the association between sodium-glucose cotransporter type 2 inhibitors (SGLT2i) and the risk of limb amputation, particularly in patients with type 2 diabetes mellitus. This review aims to provide a comprehensive understanding of the risks associated with SGLT2i therapy and to inform future research directions in this area. While SGLT2i medications, such as canagliflozin, are recognized for their cardiovascular and renal benefits, emerging evidence suggests a potential increase in the risk of lower limb amputations (LLAs) among users compared to non-users of SGLT2i. This review synthesizes findings from various studies that report a slightly elevated risk of amputation linked to SGLT2i therapy, with mechanisms proposed including diuretic-induced hypovolemia and the partial inhibition of sodium-glucose cotransporter 1. Factors such as pre-existing peripheral artery disease (PAD), sensory neuropathy, and poor foot health are identified as significant risk enhancers for lower limb amputations in this patient population. In conclusion, patients with these conditions are at increased risk of limb ischemia and subsequent amputation, and the administration of SGLT2 inhibitors may potentially further increase this risk.